SCHEMBL535875

SCHEMBL535875

O=C(O)c1c(-c2ccc(F)c(F)c2)noc1C=Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
CASP3 P42574 2/20 0.37
SENP8 Q96LD8 2/20 0.37
SENP7 Q9BQF6 2/20 0.37
SENP6 Q9GZR1 1/20 0.37
GAA P10253 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMO O15229 1/20 0.36
HTR7 P34969 1/20 0.36
HTR6 P50406 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL535874 1.00 KMT2A (0.43) KMT2AMEN1HSD17B10KDM4EMAPK1
SCHEMBL286375 0.86 CASP3 (0.48) KMT2AMEN1KDM4EMAPK1CASP3
SCHEMBL286376 0.86 CASP3 (0.48) KMT2AMEN1KDM4EMAPK1CASP3
SCHEMBL535779 0.84 KMT2A (0.50) KMT2AMEN1MAPK1MAPTGAA
SCHEMBL535778 0.84 KMT2A (0.50) KMT2AMEN1MAPK1MAPTGAA
SCHEMBL286184 0.84 KMT2A (0.48) KMT2AMEN1KDM4EMAPK1NPC1
SCHEMBL286185 0.84 KMT2A (0.48) KMT2AMEN1KDM4EMAPK1NPC1
SCHEMBL535868 0.81 HTR7 (0.38) KMT2AMEN1HSD17B10KDM4ENPC1
SCHEMBL535869 0.81 HTR7 (0.38) KMT2AMEN1HSD17B10KDM4ENPC1
SCHEMBL3985525 0.78 KMT2A (0.54) KMT2AMEN1HSD17B10KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414354-B1 Hydroxy-methyl isoxazole derivatives as gaba a modulators HOFFMANN LA ROCHE (CH) 2012-12-12 EP disclosed
US-8222246-B2 Substituted isoxazoles HOFFMANN-LA ROCHE INC. (US) 2012-07-17 US disclosed
EP-2414354-A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators F. Hoffmann-La Roche AG (CH) 2012-02-08 EP disclosed
WO-2010112475-A1 HYDROXY-METHYL ISOXAZOLE DERIVATIVES AS GABA A MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2010-10-07 WO disclosed
US-20100256127-A1 SUBSTITUTED ISOXAZOLES ROCHE PALO ALTO LLC 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256127-A1 SUBSTITUTED ISOXAZOLES GABRA5, GABRA1, GABRA3 KMT2A 2613/4885MEN1 3395/4885HSD17B10 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.